oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.
To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with oxytetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
WILKINS EA et al. | The experimental background for the clinical use of terramycin. | 1950 | Bull Johns Hopkins Hosp | pmid:15420552 |
KERSEY RC | A turbidimetric assay for terramycin. | 1950 | J Am Pharm Assoc Am Pharm Assoc | pmid:15421912 |
MORSE EV et al. | In vitro sensitivity of a number of bacteria isolated from animals, to terramycin. | 1950 | Vet Med | pmid:14776943 |
RAVAZZANI C | [Terramycin]. | 1950 | Boll Chim Farm | pmid:14777805 |
LINSELL WD and FLETCHER AP | Laboratory and clinical experience with terramycin hydrochloride. | 1950 | Br Med J | pmid:14777907 |
TERRAMYCIN. | 1950 | Br Med J | pmid:14777913 | |
MOST H and VAN ASSENDELFT F | Laboratory and clinical observations on the effect of terramycin in the treatment of amebiasis. | 1950 | Ann. N. Y. Acad. Sci. | pmid:14783352 |
HUBBARD WN and TILLETT WS | Terramycin in the treatment of pneumococcal pneumonia. | 1950 | Ann. N. Y. Acad. Sci. | pmid:14783353 |
DOWLING HF et al. | Terramycin in the treatment of pneumococcic and other bacterial infections. | 1950 | Ann. N. Y. Acad. Sci. | pmid:14783354 |
KNEELAND Y and MELCHER GW | Terramycin in the treatment of primary atypical pneumonia. | 1950 | Ann. N. Y. Acad. Sci. | pmid:14783355 |